DOCSLIB.ORG

HCG-Annual-Report.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
HCG-Annual-Report.Pdf HealthCare Global Enterprises Limited Annual Report 2018-19 About the Report The Annual Report provides a holisitic overview of HCG’s philosophy and approach to creating true value over long-term for its stakeholders, patients, employees, investors and society at large. This report marks a new milestone in HCG’s corporate reporting. It is our first Integrated Annual Report adopting the structure as described in the Integrated Reporting framework<IR> as defined by the International Integrated Reporting Council (IIRC). With this report, we have embarked on a journey of sharing our value-creation philosophy. This report contains an overview of HCG and key developments in 2018-19, with respect to the strategy, value creation and our performance, plans and ambitions for the future, how we delivered on our strategy and how we engage with our stakeholders. Reporting Scope and Reporting Framework Period The report follows the International The Annual Report focuses <IR> Framework as developed by Intellectual Capital & information on business IIRC (www.integratedreporting.org) Manufactured Capital operations of HCG Enterprises and should be read in conjunction Ltd’s India operations only, aptly with the financial statements Business model, systems and disclosed through six capitals as included herein and the notes processes, brands, data and defined by International Integrated thereto. The financial and statutory our hospital infrastructure and Reporting Council (IIRC). All the six data presented is in accordance medical equipment capitals cover information on a with the requirements of the consolidated basis. The Annual Companies Act, 2013 (including Report considers the primary the rules made thereunder), reporting period as April 01, 2018 Indian Accounting Standards, Human Capital to March 31, 2019. However, some the Securities and Exchange sections of the report represent Board of India (Listing Obligations Our team of professionals including facts and figures of previous and Disclosure Requirements) clinical specialists, paramedical, years, of our multispeciality and Regulations, 2015 and the nursing, management and fertility operations, as well as our applicable laws. administrative staff associate companies including HCG Africa and Strand, to provide The report is divided into six capitals a comprehensive view to the with adoption of integrated readers – and especially anyone reporting framework as laid out Social and Relationship Capital whose success is dependent by the International Integrated on HCG, such as our patients, Reporting Council (IIRC), followed Strategic partnerships, joint- employees, investors and other by Board report and financial ventures, networks and social stakeholders. statements. contributions Financial Capital Capital available, deployed Natural Capital and returns generated by HCG Our responsibility towards Enterprises Ltd. preserving earth’s resources Assurance statements regarding Company’s or revise any forward-looking expected financial position and statement, whether as a result of To ensure the integrity of facts results of operations, business new information, future events, or and information, the Board of plans and prospects etc. and are otherwise. Directors and management have generally identified by forward- reviewed the Annual Report and looking words such as “believe,” Stakeholder Feedback have carried out the independent “plan,” “anticipate,” “continue,” assurance on sustainability “estimate,” “expect,” “may,” “will” We welcome and appreciate any disclosures presented in the report. or other similar words. Forward constructive input and feedback The statutory auditors, KPMG India looking statements are dependent from stakeholders with regard to Limited have provided assurance on assumptions or basis the content of this report. on the financial statements and underlying such statements. We the ‘Independent Auditor’s Report’ have chosen these assumptions Email: investors@ has been duly incorporated as a or basis in good faith, and we hcgoncology.com part of this report. believe that they are reasonable Mail: HealthCare Global in all material respects. However, Enterprises Ltd., #3 Tower we caution that actual results, Forward looking Wing, Unity Buildings Complex, performances or achievements statement Mission Road, Bangalore could differ materially from those 560027, India Some information in this report expressed or implied in such may contain forward-looking forward-looking statements. We Website: https://hcgel.com/ statements which include undertake no obligation to update Annual Report Contents 2018-19 Corporate Overview Statutory Reports HCG at a Glance 002 Board of Director’s Report 064 Business Review 010 Corporate 113 Chairman’s Message 012 Governance Report Financial Overview 014 Management Discussion 138 and Analysis Industry Trends 016 Our Strategy for Responsible Growth 018 The cover design highlights Our Value Creation Model 020 Financial Statements the magnitude of cancer, as a Stakeholder Engagement 024 major health problem affecting Standalone 166 the world, while HCG continues Profile of Board of Directors 026 Financial Statements relentlessly delivering hope to Medical Milestones 028 thousands of patients. Having Consolidated 253 set a strong footprint in India, Materiality Assessment 030 Financial Statements HCG’s quality of care, outcomes Financial Capital 032 delivered through efficiencies and Manufactured Capital 036 innovations are being recognised globally as well. This report marks Intellectual Capital 040 a new chapter in HCG’s care with Human Capital 046 facts and figures that illustrates Social & Relationship Capital 052 HCG’s promise of ‘adding life to years’. Natural Capital 062 Corporate Overview CO Statutory Reports SR Visit our website to view Financial Statements FS this report online www.hcgel.com HCG at a Glance As the reality of oncology incidence and prevalence, a formidable and growing threat to health and life, stand at one end of the spectrum, the innovations of science and technology in the hands of specialists stands at the other end to counter it. HCG was founded with the ethos to provide highest quality oncology outcomes through multi-disciplinary specialist teams and state- of-the-art infrastructure and technology, and a vision to bring this impact to millions, across metros and small towns in India, Africa and emerging markets, while ensuring an enterprise with robust financial stability and performance over the long-term. Underserved Oncology markets like Africa Technology and Data driven precision medicine platform like Strand Lifesciences Reproductive medicine opportunity through Milann Fertility business Anchored by this challenging and impactful agenda, in one of the most complicated disease and market landscapes, HCG stands empowered by a bold and inspiring advocacy from all its stakeholders, and has emerged as the author behind thousands of stories of hope, blossoming in spite of multiple adversities. Leveraging the capabilities of the various faculties that today form As a patient oriented and huge need (and opportunity) our core, we can inarguably compassionate healthcare to consistently deliver good establish our emergence provider, HCG has been a quality cancer treatment and as a strong, successful and pioneer in setting-up dedicated outcomes in a market with responsible entity to address cancer hospitals since 1989 abundance in diversity and, in the growing cancer burden and a torchbearer of hopes for effect, challenges. This is also within the society. thousands of cancer patients the vision, experience and track and their families since then. record with which, we have Our growth is a testament of the made strategic investments in: 002 HealthCare Global Enterprises Limited HCG at a Glance CO SR FS Vision Mission Adding life to years by To be an acclaimed healthcare redefining healthcare through institution in pursuit of medical global innovation excellence through value- based medicine Values Quality Integrity Collaboration Enabling patients to We are honest, forthright Limitless possibilities of achieve better lives and are responsible collaborative energy corporate citizens and teamwork Innovation Leadership Innovative ways We strive to be the to ensure better best at what we do, medical outcomes both as a company and as individuals Annual Report 2018-19 003 HCG at a Glance (continued) We are one of the largest private comprehensive cancer care providers in India, with a nation- wide network. Healthcare Global Enterprise Limited (HCG), is solely dedicated to addressing unmet patient needs by delivering highest quality of care and add life to years. Since our inception, our to high-end tests across oncology comprehensive cancer care and rare disease domains through One of the facilities are equipped to provide its network of laboratories. best-in-class treatment for all Leading kinds of cancers. Our care units Brands in IVF in India comprise of specialist oncologist teams, expert physicians and trained nurses that investigate, 1989 st diagnose, and provide treatments 1 private dedicated hospital One of the for all types of cancers using offering comprehensive oncology Leading evidence based protocols and services Precision Medicine global technologies. Our business platforms in India model is structured to provide specialty focused healthcare H million services under an institutional 9,787 brand, with presence in metros Operating Revenues for and Tier 2/3 towns of India. the financial year ended 31st March 2019 Over the
Load more

Recommended publications
  • HEALTHCARE SECTOR BULLETIN QUADRIA CAPITAL March 2015: Issue 20
    HEALTHCARE SECTOR BULLETIN QUADRIA CAPITAL March 2015: Issue 20 HEALTHCARE TRENDS & IMPACT STORIES Country: Vietnam Headline: More private investments called for improving Vietnam’s healthcare sector Summary: While public hospitals are hugely over-crowded the patient-bed occupancy rate in the private sector remains rather low at many private hospitals. A recent Ministry of Health (MoH) report showed that only 5 per cent of private hospitals reported a full patient bed occupancy rate while the rate is as low from 20 to 60 per cent at 56 per cent of these private units. Head of MoH’s Financial Planning Department Nguyen Nam Lien said he believes the bottleneck would be addressed through gradually reducing subsidies the public receive at their normal hospitals. “This will stimulate the public into using the private sector facilities,” Lien said. “Support will go directly to medical insurance beneficiaries instead of going to hospitals as previously,” Lien said. This mechanism will encourage people to buy medical insurance, creating the conditions for the growth of the private sector. Promoting public-private partnership in medical services development is also important to attract private investors into the sector. The southern province of Dong Nai is a successful public-private model. Dong Nai general hospital’s second phase investment, carrying a price tag of VND1.2 trillion ($56 million) and having 700 patient-beds in scope, will go underway using private capital. Some private hospitals have seen growth such as the Hanoi French Hospital, Vimec international Hospital (Hanoi), Hoan My general hospital (Ho Chi Minh City), Hop Luc general hospital (Thanh Hoa) and Hoang Viet Thang general hospital (Hue).
    [Show full text]
  • AGM Notice.Pmd
    NOTICE Notice is hereby given that the 29th Annual General Meeting of Religare Enterprises Limited (“the Company”) will be held on Friday, September 13, 2013 at 4.30 P.M. at Air Force Auditorium, Subroto Park, New Delhi - 110010, to transact the following businesses: ORDINARY BUSINESS 1. To consider and adopt the audited Balance Sheet as at March 31, 2013, the Statement of Profit and Loss for the year ended on that date and the reports of the Board of Directors and Auditors thereon. 2. To appoint a Director in place of Mr. Ravi Umesh Mehrotra, who retires from office by rotation and being eligible, offers himself for re-appointment. 3. To appoint a Director in place of Mr. Padam Bahl, who retires from office by rotation and being eligible, offers himself for re- appointment. 4. To appoint Statutory Auditors and to fix their remuneration and in this regard to consider and if thought fit, to pass, with or without modification(s), the following resolution as an Ordinary Resolution. “RESOLVED THAT M/s Price Waterhouse, Chartered Accountants (Firm Registration No. 301112E) be and are hereby appointed as Statutory Auditors of the Company, to hold office from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting of the Company on such remuneration as shall be fixed by the Board of Directors.” SPECIAL BUSINESS 5. To consider and if thought fit, to pass, with or without modification(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT in accordance with the provisions of Section 257 and all other applicable provisions, if any, of the Companies Act, 1956 or any statutory modification(s) or re-enactment thereof, Mr.
    [Show full text]
  • September 2014 Healthcare Sector Bulletin-10
    HEALTHCARE SECTOR BULLETIN QUADRIA CAPITAL Issue 10: September 2014 HEALTHCARE TRENDS & IMPACT STORIES Country: India Headline: Dr. Amit Varma: The Healthcare Financier Summary: A critical care physician by education, Dr Amit is the Managing Partner of Quadria Capital's $300 million healthcare focused Private Equity Fund that invests in the healthcare sector across South and Southeast Asia. His team has domain experts who come with a lot of operating P&L experience, acting as strategic investors and getting hands on with the company. It is a strong belief of his that a business needs to be a regional powerhouse before trying to become national, which is what most of his portfolio companies are trying to achieve. One of the factors that he considers before investing is the management team's focus on overall profitability along with expansion. Healthcare private equity in Asia still have a long way to go and interest in the healthcare space will continue due to the huge demand supply gap, restricted public spending, and a large epidemic of life style diseases. Moving forward, the private equity landscape is changing. Unlike the past where it is just possible to make above average returns by just being a financial investor, the PE investors now need to have operating experience and deep domain skills to drive value creation. Link The Healthcare Executive, Vol 3 Issue 7, http://issuu.com/healthcareexecutive/docs/he_august_2014 (Full article is enclosed at Page 33 of this newsletter) Country: India Headline: Ex-Goldman India Head Lauds Hands–On Approach for Private Equity Summary: India’s private equity industry is entering a new chapter, now that the excesses of the last private-equity rush to the country have died down.
    [Show full text]
  • HEALTHCARE SECTOR BULLETIN QUADRIA CAPITAL Issue 5: June 2014
    HEALTHCARE SECTOR BULLETIN QUADRIA CAPITAL Issue 5: June 2014 HEALTHCARE TRENDS & IMPACT STORIES Country: Indonesia Headline: Maximize the fresh opportunities for healthcare distribution in the fast-growing Indonesian provinces to boost services for principals and consumers Summary: Government decentralization has increased the flow of funds to provinces that were previously being left behind, often in spite of the fact that some of those provinces were key sources of the nation’s wealth, such as coal, oil and gas, timber and palm oil. Now these provinces are finally starting to benefit from having a greater share of government funds and this is being reflected in comparative growth figures. The consequence for the healthcare sector is that growth will continue to be higher in the provinces as consumer purchasing power increases in those regions at a rate greater than in the major cities. In turn this will require greater attention to the provinces for achieving the desired availability of medicines and, in the case of consumer health products, more visibility. Link http://www.zuelligpharma.com.sg/sites/default/files/MP53%20Feature%20Story.pdf Country: Asia Headline: Hospital companies prepare to meet surging demand for health care in Asia Summary: Although Asia’s emerging economies are slowing, the rise of their middle classes is continuing. In Indonesia the number of middle- and upper-income consumers is expected to swell from 74m in 2013 to 141m by 2020, predicts the Boston Consulting Group. Rising incomes mean rising demand for health care. The average Chinese city-dweller’s health spending more than doubled between 2002 and 2010, estimates PwC, a firm of consultants.
    [Show full text]
  • NB Private Equity Partners: Overview Presentation
    NB Private Equity Partners: Overview Presentation Financial Information as of 30 September 2019, Unless Otherwise Noted November 2019 Why Invest in NBPE? Key Investment Merits Access to a portfolio of direct private equity investments, sourced from over 55 distinct private equity firms; diversified private company exposure without single GP risk Sourcing and execution through Neuberger Berman’s ~$80 billion private equity business Strong Historic Performance Capital appreciation from equity investments and income through dividend No second layer of management fees or carried interest on vast majority of direct investments, offering significant fee efficiency vs listed fund of funds vehicles1 1. Approximately 98% of the direct investment portfolio (measured on 30 September 2019 fair value) is on a no management fee, no carry basis to underlying third-party GPs. Key Information Document is available on NBPE’s website. NB PRIVATE EQUITY PARTNERS INVESTOR UPDATE 2 NBPE Position in the Listed Private Equity Landscape NBPE is focused on direct investments, invested alongside over 55 private equity sponsors Hyper Diversified Fund of Funds • Primary & Secondary, some co-investment NB Private Equity Partners exposure • Dual fee layer • Multi-Sponsor Exposure • Need to over-commit or • Single layer of fees on majority of 1 suffer cash drag direct investments Direct Focus, Single GP • Single GP Concentration Concentrated • Single fee layer at vehicle level, carry typically higher than NBPE Lower Higher Fee Efficiency Note: as of 30 September 2019. The above graphic is intended to be a representation of the funds’ investment strategy of direct vs fund investments and investments into third-party or funds managed by an affiliated investment manager of the listed company.
    [Show full text]
  • Overview Presentation Financial Information As of 31 August 2019, Unless Otherwise Noted October 2019 Why Invest in NBPE? Key Investment Merits
    NB Private Equity Partners: Overview Presentation Financial Information as of 31 August 2019, Unless Otherwise Noted October 2019 Why Invest in NBPE? Key Investment Merits Access to a portfolio of direct private equity investments, sourced from over 55 distinct private equity firms; diversified private company exposure without single GP risk Sourcing and execution through Neuberger Berman’s $74 billion private equity business Strong Historic Performance: 13.0% YTD IRR on direct equity investments; total portfolio 11.5% YTD IRR. Three year direct equity investments gross IRR of 18.6%; three year total portfolio gross IRR of 15.1% Capital appreciation from equity investments and income through dividend No second layer of management fees or carried interest on vast majority of direct investments, offering significant fee efficiency vs listed fund of funds vehicles1 1. Approximately 98% of the direct investment portfolio (measured on 31 August 2019 fair value) is on a no management fee, no carry basis to underlying third-party GPs. Key Information Document is available on NBPE’s website. NB PRIVATE EQUITY PARTNERS INVESTOR UPDATE 2 NBPE Position in the Listed Private Equity Landscape NBPE is focused on direct investments, invested alongside over 55 private equity sponsors Hyper Diversified Fund of Funds • Primary & Secondary, some co-investment NB Private Equity Partners exposure • Dual fee layer • Multi-Sponsor Exposure • Need to over-commit or • Single layer of fees on majority of 1 suffer cash drag direct investments Direct Focus, Single GP • Single GP Concentration Concentrated • Single fee layer at vehicle level, carry typically higher than NBPE Lower Higher Fee Efficiency Note: as of 31 August 2019.
    [Show full text]
  • Politecnico Di Torino
    POLITECNICO DI TORINO Dipartimento di Ingegneria Gestionale e della Produzione Corso di Laurea Magistrale in Engineering and Management Framing of International Social-Impact Venture Capital Funds and of Their Management Teams, Behind and Beyond Performances Relatore Prof.ssa Elisa Ughetto Correlatori Prof. Giuseppe Scellato Prof.ssa Annalisa Croce Candidato Marina Berardi April 2019 1 Contents I LIST OF ACRONYMS AND ABBREVIATIONS .......................................................................................... 4 II LIST OF FIGURES .......................................................................................................................................... 5 CHAPTER 1 OVERVIEW................................................................................................................................... 7 1.1 ABSTRACT .............................................................................................................................................. 7 1.2 FRAMING LITERATURE ........................................................................................................................... 8 CHAPTER 2 SOCIAL INVESTMENT MARKET ......................................................................................... 13 2.1 SOCIAL FINANCIAL INSTRUMENTS ............................................................................................................... 13 2.2 ACTORS IN SOCIAL INVESTMENT MARKET .................................................................................................
    [Show full text]
  • 15Th March to 31St March 2019.Pdf
    15th March to 31st March 2019 Investment and Exit Pharma packaging firm Schott Kaisha rides on Indian drug companies' injectables push 19th March 2019. The Pharma Times Schott Kaisha, the Indo-German joint venture that makes tubular ampoules, vials, glass syringes and cartridges used in pharmaceuticals and cosmetics is investing over Rs 500 crore to set up new facilities and expand existing ones...more Meghmani Finechem to invest Rs. 550 cr in expansion and new projects 15th March 2019. Chemarc Meghmani Finechem Ltd (MFL) plans to invest Rs 550 crore towards expansion of existing projects at its facility in Dahej. MFL is 57 per cent owned by Meghmani Organics Ltd...more Fund Raising Ubiqare set to raise additional funds to build next generation telehealth platform for patient follow-up 26th March 2019. Pharmabiz Ubiqare a follow-up patient care provider which is bootstrapped and having invested over Rs.30 lakh so far is looking for more funds to build its next generation telehealth platform to spur home healthcare for cancer, stroke, chronic respiratory, chronic kidney disease among others...more Alembic Pharma raises Rs 150 crore via NCDs 19th March 2019. ET Health World Drug firm Alembic Pharmaceuticals Tuesday said it has raised Rs 150 crore through the allotment of non-convertible debentures (NCDs) on private placement basis...more PharmEasy in talks with SoftBank to raise $100M: report 27th March 2019. ET Health World SoftBank Group is in early-stage talks to invest nearly $100 million in online pharma startup PharmEasy, reports Mint. Citing sources, it says that the company is eyeing a valuation of $400 million in this funding round...more Wockhardt in talks with private equity cos to raise $300 million 27th March 2019.
    [Show full text]
  • Responsible Investments in Asian Healthcare
    1 Superior Returns through Responsible Investments in Asian Healthcare Annual Review 2014 2 3 Table of Contents About Quadria Capital 6 2014 At a Glance 8 Managing Partners’ Statement 10 Long Term Investors Focused on Growth 12 Our Funds and Investors 16 Portfolio Overview 28 Impact Investing 36 2015 Outlook 38 Quadria Team 40 4 5 QuadriaQuadria MissionMission To help build great companies by being a preferred strategic partner and specialized capital provider across Asia To become the investor of choice in Asian healthcare private equity by generating superior returns To create value while benefiting the greater good of regional development 6 7 About Quadria Capital Quadria Capital provides long term value-added capital in businesses for transforming their performance Quadria Capital is an independent healthcare focused private equity firm investing in high quality healthcare companies across some of the world’s fastest growing economies in South and Southeast Asia. Supported by institutional investors, Quadria aims to make a positive transformative impact in Asia’s healthcare sector, above and beyond superior financial returns. New Delhi Founded in 2008, Quadria has invested over US$ 875 million in 13 companies across six countries in the region, through three private equity vehicles. We have focused on Kolkata building high quality leading businesses, while delivering outstanding returns to investors. To date, we have returned over US$ 925 million back to our investors. Hyderabad Bangalore Ho Chi Minh 3 Private Over Equity Vehicles US$ 1 billion in Managed Capital since 2008 Colombo Singapore Jakarta 13 Investments 2 Regional Across 6 Countries Hubs Covering South and Southeast Asia Present / Past Investee Company High Priority Quadria Office Opportunistic 8 9 2014 at a Glance Quadria Capital Fund L.P.
    [Show full text]
  • April 2015 Healthcare Sector Bulletin-15
    HEALTHCARE SECTOR BULLETIN QUADRIA CAPITAL April 2015: Issue 21 HEALTHCARE TRENDS & IMPACT STORIES Country: Thailand Headline: Second-tier cities account for growing share of Thailand's healthcare market Summary: Bangkok no longer equates to the sole Thai healthcare market. Tier-2 cities in Thailand are increasingly expanding with the growth of the private and public sectors. Approximately 19 per cent of Thailand's population lives in tier-2 cities, which include Chiang Mai, Khon Kaen, Udon Thani, Ubon Ratchathani, Nakhon Ratchasima, Chon Buri and Songkhla, compared to 13 per cent in Bangkok. Tier-2 cities have experienced the explosion of urbanisation in the last decade and as these urban populations generally possess higher purchasing power and more affordability for healthcare, they demand better standards with more affordability to pay for services in private hospitals equipped with faster and better services. The ASEAN Economic Community 2015 is expected to encourage "ribbon development" of urbanisation in tier- 2 cities and border provinces, as happened in Bangkok and its vicinities over the past decade. This is expected to further accelerate the urbanisation of tier-2 cities and border provinces, resulting in a higher number of patients who can afford premium medical care. Link http://www.nationmultimedia.com/business/Second-tier-cities-account-for-growing-share-of-Th- 30257948.html Country: India Headline: Significant rise in health expenditure urgently required Summary: President Pranab Mukherjee on Saturday inaugurated the Mid-Term Meet 2015 of the National Interventional Council of the Cardiological Society of India and said a significant rise in health expenditure is urgently required to ensure universal health coverage.
    [Show full text]
  • Landscape in Asia
    SOCIAL INVESTMENT LANDSCAPE IN ASIA INSIGHTS FROM SOUTHEAST ASIA 1 Published by the Asian Venture Philanthropy Network and Sattva in May 2017 Copyright @AVPN 2017 Email [email protected] Website www.avpn.asia Authors Aarti Mohan, Smriti Harsh, Abhishek Modi (Sattva Knowledge Centre) Production Arnav Gupta, Mehar Jossan, Deepika Ganesh, Pratik Jha, Rrishi Raote, Rebecca Detorre, Venus Sharma (Sattva Knowledge Centre) Editors Martina Mettgenberg-Lemiere, PhD Nguyen Le Phuong Anh Kevin Teo Design and Typesetting Ideasutra.in This work is licensed under the Attribution- NonCommercial-ShareAlike 4.0 International License: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. NonCommercial — You may not use the material for commercial purposes. ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. 2 ABOUT THE REPORT AVPN has identified the need for a comprehensive overview of the Asian philanthropy and social invest- ment landscape to offer social investors a guide to the opportunities for social investment in Asia. The Social Investment Landscape in Asia will be an invaluable re- source for funders and resource providers as they as- sess the opportunities and challenges for philanthropy and social investment in the region. It is designed to be a guide for both new social investors looking to enter the Asian market and existing social investors exploring cross-border or cross-sector opportunities within the region. The Landscape is another way to further AVPN’s mission to increase the flow of finan- cial, human and intellectual capital to the Asian social sector.
    [Show full text]
  • Purchasing Power? Bain & Co’S Jim Verbeeten on Creating Value PE Investors Find New Ways to Unlock Value in Japan’S Consumer Sector Page 9 Page 19
    Asia’s Private Equity News Source avcj.com June 16 2015 Volume 28 Number 22 EDITOR’S VIEWPOINT Investors wait for nore big-ticket deal flow Page 3 NEWS Apax, Archer, CITIC Goldstone, Future Fund, Hony, KKR, MLC, Quadria, Sequoia, Shoreline, TPG Page 5 FOCUS Why local banks are still a force in deal-sourcing Page 14 INDUSTRY Q&A Masamichi Yoshizawa of The Longreach Group Page 15 CONTRIBUTED ARTICLE Purchasing power? Bain & Co’s Jim Verbeeten on creating value PE investors find new ways to unlock value in Japan’s consumer sector Page 9 Page 19 ANALYSIS FOCUS A boardroom battle Monetizing science Japan’s corporate governence challenge Page 12 Venture capital taps university start-ups Page 16 PRE-CONFERENCE ISSUE AVCJ PRIVATE EQUITY AND VENTURE CAPITAL FORUM JAPAN 2015 Anything is possible if you work with the right partner Unlocking liquidity for private equity investors www.collercapital.com London, New York, Hong Kong EDITOR’S VIEWPOINT [email protected] Managing Editor Tim Burroughs (852) 3411 4909 Staff Writers Andrew Woodman (852) 3411 4852 Winnie Liu (852) 3411 4907 Large check limbo Holden Mann (852) 3411 4964 Creative Director Dicky Tang Designers IT IS NOT A PHENOMENON UNIQUE TO more in 2014 – and 11, 14 and 11 in the three Catherine Chau, Edith Leung, Mansfield Hor, Tony Chow Japan. Pick a major Asian market with public years before that – the mid-market space is not markets trading at or close to an all-time high discouraging. While valuations are a concern, Senior Research Manager and you find a cumulative private equity industry participants say they can rely on a steady Helen Lee investment figure that is lagging the previous stream of opportunities involving companies Research Associates Herbert Yum, Jason Chong, year’s pace.
    [Show full text]